{"task_id": "ec5132784262f6ab", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 871/905)", "text": "/pdfs/journals/lancet/PIIS0140-6736(08)60109-9.pdf\n\n--- Page 877 ---\n863\nReferences\n50 Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of GCA. Rheuma-\ntology (Oxford) 2010; 49(8):1594\u20137. http://rheumatology.oxfordjournals.org/content/49/8/1594.long\n51 Dasgupta B, Giant Cell Arteritis Guideline Development Group. Concise guidance: diagnosis and \nmanagement of giant cell arteritis. Clin Med (Lond) 2010; 10(4):381\u20136. https://www.ncbi.nlm.nih.gov/pub-\nmed/20849016\n52 Stephens RS, Brown C. Persistent lower abdominal and groin pain: what is the diagnosis? Am J Med \n2005; 118(4):364\u20137. http://www.amjmed.com/article/S0002-9343(05)00088-4/abstract\n53 Weiner SM, Peter HH. Neuropsychiatric involvement in systemic lupus erythematosus. Part 1: \nclinical presentation and pathogenesis. Med Klin 2002; 97(12):730\u20137. https://www.ncbi.nlm.nih.gov/pub-\nmed/12491066 \n54 Reilly PA, Littlejohn GO. Peripheral arthralgic presentation of \ufb01 brositis/\ufb01 bromyalgia syndrome. J \nRheum 1992; 19:281\u20133 https://www.ncbi.nlm.nih.gov/pubmed/1629829\n55 Richards SC, Scott DL. Prescribed exercise in people with \ufb01 bromyalgia: parallel group randomised con-\ntrolled trial. BMJ 2002; 325:185\u20139. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117444/\n56 Busch AJ, Schachter CL, Overend TJ, et al. Exercise for \ufb01 bromyalgia: a systematic review. J Rheumatol \n2008; 35:1130\u201344. https://www.ncbi.nlm.nih.gov/pubmed/18464301\n57 Goldenberg DL. Multidisciplinary modalities in the treatment of \ufb01 bromyalgia. J Clin Psychiatry 2008; 69 \nSuppl 2:25\u20139. https://www.ncbi.nlm.nih.gov/pubmed/18537461\n58 NICE. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and \nmanagement [CG53]. 2007. https://www.nice.org.uk/Guidance/cg53\n59 New Zealand Guidelines Group. New Zealand acute low back pain guide. 2004. http://www.acc.co.nz/\nPRD_EXT_CSMP/groups/external_communications/documents/guide/prd_ctrb112930.pdf \n60 Schneider M, Vernon H, Ko G, et al. Chiropractic management of \ufb01 bromyalgia syndrome: a system-\natic review of the literature. J Manipulative Physiol Ther 2009; 32:25\u201340. https://www.ncbi.nlm.nih.gov/\npubmed/19121462\n61 Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal \ufb02 uid levels of substance P in patients with the \n\ufb01 bromyalgia syndrome. Arthritis Rheum 1994; 37:1593\u2013601. https://www.ncbi.nlm.nih.gov/pubmed/7526868\n62 Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal \ufb02 uid biogenic amine metabolites in \ufb01 bromyalgia/\n\ufb01 brositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35:550\u20136. https://www.ncbi.nlm.nih.\ngov/pubmed/1374252\n63 Wood PB, Schweinhardt P, Jaeger E, et al. Fibromyalgia patients show an abnormal dopamine response \nto pain. Eur J Neurosci 2007; 25:3576\u201382. https://www.ncbi.nlm.nih.gov/pubmed/17610577\n64 Reichrath J, Bens G, Bonowitz A, et al. Treatment recommendations for pyoderma gangrenosum: an \nevidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; \n53(2):273\u201383. https://www.ncbi.nlm.nih.gov/pubmed/16021123\nChapter 13: Surgery\n1 American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the \nuse of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients \nundergoing elective procedures: an updated report by the American Society of Anesthesiologists Com-\nmittee on Standards and Practice Parameters. Anesthesiology 2011; 114(3):495\u2013511. https://www.ncbi.nlm.\nnih.gov/pubmed/21307770\n2 General Medical Council. Consent: Patients and doctors making decisions together. 2008. http://www.\ngmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp\n3 BAPEN. Screening & \u2018MUST\u2019. 2016. http://www.bapen.org.uk/screening-and-must/must\n4 NICE. Anticoagulation\u2014oral [Clinical Knowledge Summaries]. 2015. http://cks.nice.org.uk/anticoagu-\nlation-oral#!management\n5 NIE. Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma [TA268]. \n2012. https://www.nice.org.uk/guidance/ta268\n6 Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic \nmelanoma. N Engl J Med 2010; 363(8):711\u201323. http://www.nejm.org/doi/full/10.1056/NEJMoa1003466\n7 NICE. Early and locally advanced breast cancer: Diagnosis and treatment [CG80]. 2009. https://www.\nnice.org.uk/guidance/cg80\n8 NICE. Advanced breast cancer: Diagnosis and treatment [CG81]. 2009, updated 2014. https://www.\nnice.org.uk/guidance/cg81\n9 NICE. Obesity: Identi\ufb01 cation, assessment and management [CG189]. 2014. https://www.nice.org.uk/\nguidance/cg189.\n10 Halpin V. Early cholecystectomy. BMJ Best Practice. http://bestpractice.bmj.com/best-practice/evi-\ndence/intervention/0411/0/sr-0411-i1.html\n11 NICE. Varicose veins: Diagnosis and management [CG168]. 2013. https://www.nice.org.uk/guidance/\ncg168\nChapter 14: Clinical chemistry\n1 NICE. Intravenous \ufb02 uid therapy in adults in hospital [CG174]. 2013. https://www.nice.org.uk/Guidance/\ncg174\n2 Levey A, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular \ufb01 ltration rate from \nserum creatinine: a new prediction equation. Modi\ufb01 cation of Diet in Renal Disease Study Group. Ann Intern \nMed 1999; 130:461\u201370. https://www.ncbi.nlm.nih.gov/pubmed/10075613\n3 Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, \nunsteadiness, and attention de\ufb01 cits. Am J Med 2006; 119:71.e1\u20138. https://www.ncbi.nlm.nih.gov/pub-\nmed/16431193\n4 Robertson GL. Vaptan for the treatment of hyponatraemia. Nat Rev Endocrinol 2011; 7:151\u201361. http://\nwww.nature.com/nrendo/journal/v7/n3/full/nrendo.2010.229.html \n5 Smellie S. Spurious hypokalaemia. BMJ 2007; 334:693. http://www.bmj.com/content/334/7595/693 \n6 Thomas J, Doherty SM. HIV infection--a risk factor for osteoporosis. J Acquir Immune De\ufb01 c Syndr 2003; \n33(3):281\u201391. https://www.ncbi.nlm.nih.gov/pubmed/12843738", "text_length": 5894, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 871/905)", "type": "chunk", "chunk_index": 870, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.687841", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.689187", "status": "complete", "chunks_added": 4}